UTOPIA

K052249 · Respcare, Inc. · BZD · Dec 7, 2005 · Anesthesiology

Device Facts

Record IDK052249
Device NameUTOPIA
ApplicantRespcare, Inc.
Product CodeBZD · Anesthesiology
Decision DateDec 7, 2005
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 868.5905
Device ClassClass 2
AttributesTherapeutic

Intended Use

The Utopia is intended for use by adults (> 30 kg) as a patient interface for currently-marketed CPAP or bi-level positive-pressure ventilation devices for treatment of respiratory insufficiencies and obstructive sleep apnea. (Applies to the standard version): For homecare applications, the Utopia may be reused multiple times by a single patient. For clinical applications (i.e. hospital or other clinical settings), this interface may be reused multiple times by multiple patients. (Applies to the Disposable version): The Utopia Disposable is a single patient, single use interface.

Device Story

Utopia is a patient interface (mask) for CPAP or bi-level ventilators; delivers positive airway pressure to oral and nasal passages. Device features include forehead pad, headgear for secure facial seal, exhalation port, anti-asphyxia valve, and oxygen entrainment port. Connects to ventilators via standard 22 mm fitting. Used in home or clinical settings; operated by patients or healthcare providers. Provides non-invasive ventilation support to treat respiratory insufficiency and obstructive sleep apnea; benefits patient by maintaining airway patency.

Clinical Evidence

No clinical data. Substantial equivalence is based on functional testing and comparison of materials and design to legally marketed predicate devices.

Technological Characteristics

Patient interface mask with forehead pad and headgear. Features include 22 mm standard ventilator connection, exhalation port, anti-asphyxia valve, and oxygen entrainment port. Available in single-use (disposable) and multi-use versions. Materials are comparable to predicate masks. Non-powered, passive device.

Indications for Use

Indicated for adults (> 30 kg) requiring CPAP or bi-level positive-pressure ventilation for respiratory insufficiency or obstructive sleep apnea.

Regulatory Classification

Identification

A noncontinuous ventilator (intermittent positive pressure breathing-IPPB) is a device intended to deliver intermittently an aerosol to a patient's lungs or to assist a patient's breathing.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K 0522 49 #### DEC 7 2005 # 510(k) SUMMARY | Submitter's Name: | RespCare Inc. | |----------------------|-------------------------------------------------------------------------------------------------------------| | Submitter's Address: | 6601 Lyons Road, Suites B1-B4<br>Coconut Creek, FI 33073, USA | | Telephone Number: | (561) 208-3778 | | Fax Number: | (954) 727-8479 | | Contact Person: | Frank Pelc | | Date: | August 17, 2005 | | Proprietary Name: | Utopia | | Common/Usual Name: | Face Mask | | Classification: | Class II, CFR 868.5905, BZD | | Classification Name: | Accessory to Noncontinuous Ventilator | | Predicate Devices: | K030822 -- Hans Rudolph 7600 Vmask<br>K040506 - Fisher & Paykel HC431<br>K002465 - Respironics PerformaTrak | #### Device Description The Utopia is a patient interface accessory to a positive pressure ventilator intended for treatment of respiratory insufficiencies and obstructive sleep apnea. The device delivers positive airway pressure from a CPAP or bi-level device to the patient's oral and nasal passages. Connection to the ventilator device is made by a standard 22 mm fitting. The mask is held in place on the face by a forehead pad and headgear worn around the head. The device includes exhalation port. anti-asphyxia valve, and oxygen entrainment port features. #### Comparison to Predicate Devices The Utopia is essentially similar to the legally marketed predicate interfaces listed above in function, intended use, materials, and features. Both the proposed device and the predicates are intended to be used as a patient interface for currently-marketed CPAP or Bi-Level positive-pressure ventilation devices for treatment of respiratory insufficiencies and obstructive sleep apnea. The Utopia is offered in single use and multiple patient, multiple use versions. Predicate examples are offered for both single and multiple use for comparison. Like the predicate masks, the Utopia delivers non-invasive positive airway pressure from a CPAP or bi-level flow generator to the patient's oral and nasal passages. The Utopia provides a seal against the face as it is held in place with a headgear worn around the head similar to the predicates. Exhalation ports are provided on the mask shell. An anti-asphyxia valve is provided as a safety feature in case of low pressure delivery from the ventilator device. Accessory ports for oxygen entrainment are provided. Each of these features is comparable to predicates mentioned above. Materials used in the Utopia are comparable to the predicates as well. {1}------------------------------------------------ # Substantial Equivalence The Utopia is equivalent to the predicate devices in intended use, environment of use, patient population, and frequency of use. Its basic method of operation and design is also equivalent to the predicates, as described in the comparison above. Materials information and functional testing relative to the intended use of the Utopia show that it is as safe and effective as the predicate devices. As such, it is RespCare's conclusion that the Utopia is substantially equivalent to the predicate devices. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three wavy lines, which are meant to represent the human form. DEC 7 2005 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Mr. Frank Pelc Director, Regulatory Affairs and Quality Compliance Respeare, Incorporated 6601 Lyons Road, Suites B1-B4 Coconut Creek, Florida 33073 Re: K052249 Trade/Device Name: Utopia Regulation Number: 868.5905 Regulation Name: Noncontinuous Ventilator (IPPB) Regulatory Class: II Product Code: BZD Dated: November 3, 2005 Received: November 4, 2005 Dear Mr. Pelc: We have reviewed your Section 510(k) premarket notification of intent to market the device we nave revers and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device mensiale continered prior station been reclassified in accordance with the provisions of Amendinens, or to actriced Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general approvin applied.com (1) he Act. The general controls provisions of the Act include controls provided registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting (1 Nr), it may of badyos to another of Federal Regulations, Title 21, Parts 800 to 898. In your device ear or routersh further announcements concerning your device in the Federal Register. {3}------------------------------------------------ Page 2 - Mr. Pelc Please be advised that FDA's issuance of a substantial equivalence determination does not I least to advised that 1 Dr. e tormination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. or the Act of any I ederal the Act's requirements, including, but not limited to: registration 1 od intiles comply was 807); labeling (21 CFR Part 801); good manufacturing practice and fisting (21 es result in the quality systems (QS) regulation (21 CFR Part 820); and if requirences as tectronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) This fetter will anon your be of a finding of substantial equivalence of your device to a premaired predicated predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), rr you desire it the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You entriod, "Wherehalled" information on your responsibilities under the Act from the Inter of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Suttie y. Michie ond Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health {4}------------------------------------------------ # INDICATIONS FOR USE ### 510(k) Number (if known): ## Device Name: Utopia #### Indications for Use: The Utopia is intended for use by adults (> 30 kg) as a patient interface for currently-marketed CPAP The Glopia is mendou for accoby adults ( obstructive sleep apnea. (Applies to the standard version): (Applies to the standard version); For homecare applications, the Utopia may be reused multiple times by a single patient. For i of nomeoure applications (i.e. hospital or other clinical settings), this interface may be reused multiple times by multiple patients. (Applies to the Disposable version): The Utopia Disposable is a single patient, single use interface. Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) W. Mela for A. Graham v. Genoral Hospital. Page 1 of Number: K 052277
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...